Alexandria is best positioned to continue to reinforce the bedrock of the biotech sector which actually will celebrate its 50th anniversary next year on the founding of Genentech. This sector is ...

Alexandria is best positioned to continue to reinforce the bedrock of the biotech sector which actually will celebrate its 50 anniversary next year on the founding of Genentech. This sector is the ...

Hallie Kuhn; Senior Vice President, Science & Technology and Capital Markets; Alexandria Real Estate Equities Inc Peter Moglia; Co-President and Regional Market Director, San Diego; Alexandria Real ...

Though the new shuttles will be emblazoned with the city logo, they will be operated by ... BART and private companies such as Google and Genentech. Some will be hybrids, others will be electric ...

Genentech plans to invest more than $700 million in a new 700,000-ft 2 drug manufacturing facility in Holly Springs, NC. The project is expected to add more than 400 manufacturing jobs when the ...

Genentech, a biotechnology company and member of the Roche Group, announced on May 12, 2025, that it will invest more than $700 million in a new, state-of-the-art drug manufacturing facility in Holly ...

The company will establish a new 700,000-square-foot, high-volume fill-finish operation in Wake County to support its existing product portfolio as well as its future pipeline, allowing Genentech ...

WASHINGTON — North Carolina Governor Josh Stein announced Monday that Genentech will invest $700 million to construct a new manufacturing plant in Holly Springs, creating 400 jobs. "World-class ...

HOLLY SPRINGS, N.C. (WTVD) -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million manufacturing plant in Wake County, creating over 400 new jobs ...

PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics within oncology and inflammation, today announced Barbara Duncan has joined ...

Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted medicines in the autoimmune disease space. Flagship Pioneering-backed ...

RALEIGH, N.C., May 13, 2025 /PRNewswire/ -- Genentech, one of the world's premiere biotechnology companies headquartered in South San Francisco, California, announced it will build a new ...